GODREJ AGROVET LTD (NSE: GODREJAGRO) Q3 2026 Earnings Call dated Feb. 04, 2026
Corporate Participants:
Nadir Godrej — Chairman and Non-executive Director
Analysts:
Shivansh Singh — Analyst
Presentation:
operator
Ladies and gentlemen, good day and welcome to Godrej Aggravate Limited Q3FY26 earnings conference call hosted by. Equerious securities Private Limited. As a reminder, all participant lines will win the listen only mode and there will be an opportunity for you to ask questions after the presentation can close. Should you need assistance during this conference call, please signal an operator by pressing Star then zero on your touchtone phone. Please note that this conference is being recorded. Now hand the conference over to Mr. Shivansh from Equerrius Securities Private Ltd. Thank you. And over to you sir.
Shivansh Singh — Analyst
Thank you. Good afternoon everyone. And thank you for joining us on The Godrej aggravate Q3 FY26 earnings conference call from the company. We have with us Mr. Nader Godrej, Chairman of the company Mr. Sunil Kataria, Chief Executive Officer. Sir, and managing director Mr. S. Vardaraj, chief financial officer Mr. Burgess godrej, managing director, astec life sciences and Mr. Arjit mukherjee, chief operating officer, astec life sciences. We would like to begin the call with. With brief opening remarks from the management following which we will have the forum open for an interactive question and answer session. Before we start, I would like to point out that some statements made in today’s call may be forward looking and a disclaimer to this effect has.
Included in the earnings presentation shared with you earlier. I would now like to invite Mr. Nadesh Godrej to make the initial remarks. Over to you, Sir.
Nadir Godrej — Chairman and Non-executive Director
Good afternoon everyone. I welcome you all to the Godrich Aggrevet Earnings Call. Now. I will comment on the business update for quarter three. Fiscal year 26 aggregate delivered a strong performance in quarter three fiscal year 26 with consolidated revenues growing by. 11% year on year and profitability accelerating sharply reflected in a 23% year on year increase in profit before tax before exceptional. This was driven by disciplined margin expansion, operational efficiencies and strong contributions from the vegetable oil, animal feed, poultry and processed foods businesses. Alongside a sharp turnaround in astec. For the nine months ended 31 December 2025, the company reported consolidated revenues of 7,000.
900 crore rupees, an increase of 9% year on year. Profit before tax excluding non recurring and exceptional items for the period was 482 crore rupees, A healthy 17% year on year growth coming to the key financial and business highlights of each of our business segments, the animal feed segment delivered another quarter of strong volume led growth. With volumes up 12% year on year in quarter three. Notably cattle feed volumes grew by 21% contributing meaningfully to the overall expansion. The underlying. Underlying Segment result grew 17% year on year and underlying ebit per metric ton improved to 2020 rupees per metric ton in quarter.
3 fiscal year 26 from rupees 1937 per metric ton in quarter 3 fiscal year 25. Our vegetable oil. The business continued to deliver stellar performance with Segment revenue growing 27% year on year and 25% growth in segment results driven. By improved fresh fruit punch arrivals and a better oil extraction ratio. The crop protection business delivered a 30. 7% year on year revenue growth driven by higher salience of generics and select specialty products. Segment results were flat reflecting the impact of lower volumes in both in life. And in house portfolios due to unseasonal rains and cyclones across key markets.
Aztec Life Sciences registered a strong recovery with revenues growing 33. year on year driven by robust volume growth across both the enterprise and CDMO segments. The EBITDA for the quarter turn positive. At 5 crore rupees, a sharp improvement compared to a loss in the same period last year supported by higher volumes and improved gross margins. In the. Enterprise category, creamline dairy recorded a 3% year on year revenue growth supported by stable volumes across key product categories. Profitability, however, remained under. Pressure with ebitda declining to 11 crore rupees and margins softening to 3% primarily due to higher milk procurement costs and a shortfall in revenue.
Go Rich Food delivered stable revenues of 215 crore rupees. Profitability strengthened six. Significantly with EBITDA growing 51% year on year to 17 crore rupees and margins expanding to 8%. Supported by improved contribution margin. In the branded portfolio and better live bird prices. The business continued to advance its strategic shift toward value added offerings with branded sale. Rising to 81% in quarter three from 77% last year. Thank you.
operator
So, can we start with the Q and A?
Nadir Godrej — Chairman and Non-executive Director
Yes, yes please.
operator
Okay, sir. Thank you very much. We will now begin the question.